These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 19795443)
1. Tumor suppressor function of Rab25 in triple-negative breast cancer. Cheng JM; Volk L; Janaki DK; Vyakaranam S; Ran S; Rao KA Int J Cancer; 2010 Jun; 126(12):2799-812. PubMed ID: 19795443 [TBL] [Abstract][Full Text] [Related]
2. TOB suppresses breast cancer tumorigenesis. O'Malley S; Su H; Zhang T; Ng C; Ge H; Tang CK Int J Cancer; 2009 Oct; 125(8):1805-13. PubMed ID: 19569230 [TBL] [Abstract][Full Text] [Related]
3. Dipyridamole prevents triple-negative breast-cancer progression. Spano D; Marshall JC; Marino N; De Martino D; Romano A; Scoppettuolo MN; Bello AM; Di Dato V; Navas L; De Vita G; Medaglia C; Steeg PS; Zollo M Clin Exp Metastasis; 2013 Jan; 30(1):47-68. PubMed ID: 22760522 [TBL] [Abstract][Full Text] [Related]
4. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin. Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698 [TBL] [Abstract][Full Text] [Related]
5. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt. Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605 [TBL] [Abstract][Full Text] [Related]
6. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro. Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303 [TBL] [Abstract][Full Text] [Related]
8. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233 [TBL] [Abstract][Full Text] [Related]
9. Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy. Volk-Draper LD; Rajput S; Hall KL; Wilber A; Ran S Neoplasia; 2012 Oct; 14(10):926-42. PubMed ID: 23097627 [TBL] [Abstract][Full Text] [Related]
10. Loss of RAB25 expression in breast cancer. Cheng JM; Ding M; Aribi A; Shah P; Rao K Int J Cancer; 2006 Jun; 118(12):2957-64. PubMed ID: 16395697 [TBL] [Abstract][Full Text] [Related]
11. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis. Yin YX; Shen F; Pei H; Ding Y; Zhao H; Zhao M; Chen Q Tumour Biol; 2012 Oct; 33(5):1581-7. PubMed ID: 22644676 [TBL] [Abstract][Full Text] [Related]
13. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842 [TBL] [Abstract][Full Text] [Related]
14. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437 [TBL] [Abstract][Full Text] [Related]
15. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis. García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914 [TBL] [Abstract][Full Text] [Related]
16. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer. Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716 [TBL] [Abstract][Full Text] [Related]
18. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo. Fan Y; Xin XY; Chen BL; Ma X Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986 [TBL] [Abstract][Full Text] [Related]
20. [Expression of vascular endothelial cell growth factor and its receptor mRNA in breast cancer tissues]. Liu X; Fan P; Wang S; Wu ZY Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):119-21. PubMed ID: 12783674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]